Keyphrases
Protective Immunity
100%
Plasmid
100%
Live Attenuated
100%
Live Attenuated Vaccine
100%
Zika Vaccine
100%
DNA Vaccine
20%
Single-dose Vaccine
20%
Cold Chain
20%
Virus
10%
T Cell Response
10%
Neutralizing Activity
10%
Pregnant Rats
10%
Complementary DNA (cDNA)
10%
University of Texas
10%
Effective Means
10%
Immunization
10%
Vaccination
10%
Vaccine Candidate
10%
Vaccine Development
10%
Cell Culture
10%
Infectious Diseases
10%
Sterilizing Immunity
10%
National Institutes of Health
10%
RNA Virus
10%
Further Development
10%
Universal Vaccine
10%
Centers for Disease Control
10%
Infectious Virus
10%
Disease Prevention
10%
Vaccine Approaches
10%
Public Health Emergency of International Concern (PHEIC)
10%
Vaccine Platform
10%
Plasmid DNA (pDNA)
10%
Rapid Onset
10%
Neutralizing Antibodies
10%
Seroconversion
10%
Male Mice
10%
Testicle
10%
AG129 Mice
10%
Fetal Serum
10%
Oligospermia
10%
Future Vaccines
10%
Adventitious Agents
10%
Chemical Stability
10%
Fetal Transmission
10%
Onset of Immunity
10%
Immunology and Microbiology
Plasmid
100%
Attenuated Vaccine
100%
Live Vaccine
100%
Zika Virus Vaccine
100%
Zika Virus
60%
Mouse
50%
Vaccine Efficacy
40%
Vaccination Policy
20%
DNA Vaccine
20%
T Cell
10%
Virus Infectivity
10%
Infectious Agent
10%
Cell Culture
10%
RNA Virus
10%
Infectious Disease
10%
Antibody Titer
10%
Neutralizing Antibody
10%
Seroconversion
10%
Orchitis
10%
Pharmacology, Toxicology and Pharmaceutical Science
Live Vaccine
100%
Zika Virus Vaccine
100%
Zika Virus
60%
Mouse
50%
Disease
20%
Vaccination Policy
20%
DNA Vaccine
20%
Injury
10%
Infection
10%
Infectious Agent
10%
Vaccine Development
10%
Cell Culture
10%
Complementary DNA
10%
Virus Infectivity
10%
Neutralizing Antibody
10%
Virus RNA
10%
Plasmid DNA
10%
Chemical Stability
10%
DNA A
10%
Orchitis
10%
Oligospermia
10%